Relmada Therapeutics (RLMD) shares were up nearly 11% in afternoon trading on Friday after the company's Chief Executive Officer Sergio Traversa and Chief Financial Officer Maged Shenouda bought 200,000 shares each, according to separate regulatory filings.
Trading volume stood at over 1.7 million shares against a daily average of about 1.8 million.
Price: $4.52, Change: $+0.44, Percent Change: +10.93%
National Beverage (FIZZ) reported fiscal Q1 earnings late Thursday of $0.50 per diluted share, down from $0.60 a year earlier.One analyst polled by FactSet expected $0.59.Revenue in the three months ended Aug. 1 rose to $330.7 million from $330.5 million a year earlier.One analyst projected $342.1 million.National Beverage shares fell 3% in after-hours trading.
Zumiez (ZUMZ) reported Thursday Q2 loss of $0.17 per diluted share, compared with loss of $0.06 a year earlier.Two analysts surveyed by FactSet expected a loss of $0.14.Revenue for the quarter ended Aug. 1 was $209.0 million, down from $214.3 million a year ago.Two analysts expected $212.1 million.The company expects Q3 EPS of $0.00 to $0.10 on revenue of $222 million to $226 million. Two analysts expect EPS of $0.59, if comparable, and revenue of $238 million.Shares of the company fell over 15% in after-hours trading.
Box (BOX) entered a collaboration with OpenAI to launch an integration that lets users access and work with business content stored in its platform directly from ChatGPT.The integration can help accelerate clinical research, streamline legal workflows, and support financial analysts reviewing company reports, Box said Thursday in a statement.The feature is available starting Thursday for Box customers, with OpenAI rolling out access to users of ChatGPT's paid tiers over the coming days.Price: $34.10, Change: $-0.39, Percent Change: -1.13%